Drug Trial Radar · NCT01644877
A Phase II, Randomized, Double-blind, Placebo-controlled Study to Examine the Effects of DAS181 in Immunocompromised Subjects With Lower Respiratory Tract Parainfluenza Infection on Supplemental Oxygen
Last checked: Nov 19, 2026Latest source record: Sep 25, 2017 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
111
Actual
Start
Mar 2014
Primary completion
Dec 15, 2016
Study completion Dec 15, 2016
Sponsor
- Lead sponsor
- Ansun Biopharma, Inc.Industry
- Sponsor type
- Industry
- First posted
- Jul 19, 2012
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 12 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This protocol will seek to enroll immunocompromised patients who are on supplemental oxygen and diagnosed with a parainfluenza infection.
Conditions
- Parainfluenza
Interventions
DAS181 dry powder, formulation F02Drug
Lactose PlaceboDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Clinical StabilityTime frame: 45 days
Locations
45 sites in 1 country. Site status is shown where the registry gives one.
Mayo Clinic-Arizona
Phoenix, Arizona
City of Hope
Duarte, California
Children's Hospital of Orange County
Orange, California
Stanford University Medical Center
Palo Alto, California
UC Davis
Sacramento, California
Ansun Biopharma, Inc
San Diego, California
Children's Hospital Colorado
Aurora, Colorado
Lurie Children's Hospital
Chicago, Illinois
University of Chicago
Chicago, Illinois
Loyola University Medical Center
Maywood, Illinois
Indiana Blood and Marrow Transplantation
Indianapolis, Indiana
University of Iowa
Iowa City, Iowa
Children's Mercy Hospital
Kansas City, Kansas
University of Kansas
Kansas City, Kansas
John Hopkins University School of Medicine
Baltimore, Maryland
Beth Israel Deaconess Medical Center
Boston, Massachusetts
Brigham & Women's Hospital
Boston, Massachusetts
University of Michigan
Ann Arbor, Michigan
University of Minnesota, School of Medicine
Minnesota City, Minnesota
Washington University School of Medicine
St Louis, Missouri
Hackensack University Medical Center
Hackensack, New Jersey
Weill Cornell Medical College/New York Presbyterian Hospital
New York, New York
Weill Cornell Medical College-Peds
New York, New York
University of Rochester Medical Center
Rochester, New York
Stonybrook
Stony Brook, New York
Montefiore Medical Center
The Bronx, New York
Duke University Medical Center
Durham, North Carolina
Cincinnati Children's Hospital
Cincinnati, Ohio
Cleveland Clinic
Cleveland, Ohio
Nationwide Children's
Columbus, Ohio
University of Oklahoma
Oklahoma City, Oklahoma
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania
Medical University of South Carolina
Charleston, South Carolina
St. Jude Children's Research Hospital
Memphis, Tennessee
Vanderbilt- Henry-Joyce Cancer Clinic
Nashville, Tennessee
Baylor College of Medicine
Houston, Texas
Texas Children's Hospital
Houston, Texas
The University of Texas MD Anderson Cancer Center
Houston, Texas
Showing 40 of 45 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.